Coronavirus

HHS is securing Pfizer and BioNTech’s BNT162 vaccine as soon as FDA approves.

Many families fell behind on vaccines during the pandemic, but a study finds most clinics are available to schedule make-up appointments.

The test is not FDA approved, but is instead authorized for emergency use in the context of the SARS-CoV-2 pandemic.

A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.

Should we be reconsidering the length of time patients are isolated?

The FDA clears way for next phase for abivertinib to treat hospitalized patients.

A single injection of the Ad5-vectored COVID-19 vaccine induced specific immune responses to the spike glycoprotein at day 28.

This was seen in patients who were receiving either invasive mechanical ventilation or oxygen.

The development of BNT162 is based on BioNTech’s mRNA platform; the vaccine will then be produced using Pfizer’s vaccine manufacturing capacities.

New data shows the ChAdOx1 nCoV-19 vaccine candidate induces T cell response within 14 days, and antibody response within 28 days.

Luminex Receives FDA Emergency Use Authorization for its xMAP SARS-CoV-2 Multi-Antigen IgG Assay.

Quest Diagnostics will now able to efficiently test larger groups of specimen among persons from low-coronavirus risk areas.

Results highlight burden of disease and potential issues associated with contact tracing.

Perspective on how the anticoagulant could progress to human trials and potentially, marketing use for coronavirus prevention.

In a small Italian study, a majority of patients who were hospitalized and recovered from the virus, had lingering symptoms and many had a “worsened quality of life.”

Asymptomatic and presymptomatic cases of COVID-19 create challenges for identifying and combating the spread of the virus in detention facilities.

A discussion with an RPI investigator after promising early findings.

A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.

West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.

A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.

A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.

Tens of thousands of patients were prescribed the anti-malarial drugs in the early weeks of the pandemic, a statistic that concerns public health officials.

Heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute.

Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.

Following an outbreak of both COVID-19 and H1N1 influenza, Parisian hospital admissions for Kawasaki disease increased.

Skilled nursing facilities are facing an unprecedented crisis as deaths rise amid the COVID-19 pandemic while admissions and patient census decline, a new study shows.

The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.